Global Glioblastoma Multiforme Treatment (GBM) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 120 pages | ID: G00CDFF9D5FGEN
GlobalInfoResearch

Abstracts

Glioblastoma is a fast-growing, aggressive type of central nervous system tumor that forms on the supportive tissue of the brain.

SCOPE OF THE REPORT:

This report studies the Glioblastoma Multiforme Treatment (GBM) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glioblastoma Multiforme Treatment (GBM) market by product type and applications/end industries.
Global glioblastoma multiforme treatment market is expected to witness significant growth over the forecast period owing to the rising incidence of oncology diseases and rising geriatric population base.
The global Glioblastoma Multiforme Treatment (GBM) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glioblastoma Multiforme Treatment (GBM).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers

• Merck
• Teva Pharmaceutical
• Arbor Pharmaceuticals
• Sun Pharmaceutical
• Roche

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Chemotherapy
• Radiotherapy
• Gene therapy
• Molecular biotechnology

Market Segment by Applications, can be divided into

• Bevacozumab
• Carmustine
• Temozolomide

Contents

1 GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET OVERVIEW

1.1 Product Overview and Scope of Glioblastoma Multiforme Treatment (GBM)
1.2 Classification of Glioblastoma Multiforme Treatment (GBM) by Types
  1.2.1 Global Glioblastoma Multiforme Treatment (GBM) Revenue Comparison by Types (2017-2023)
  1.2.2 Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Types in 2017
  1.2.3 Chemotherapy
  1.2.4 Radiotherapy
  1.2.5 Gene therapy
  1.2.6 Molecular biotechnology
1.3 Global Glioblastoma Multiforme Treatment (GBM) Market by Application
  1.3.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Bevacozumab
  1.3.3 Carmustine
  1.3.4 Temozolomide
1.4 Global Glioblastoma Multiforme Treatment (GBM) Market by Regions
  1.4.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Glioblastoma Multiforme Treatment (GBM) Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Glioblastoma Multiforme Treatment (GBM) Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glioblastoma Multiforme Treatment (GBM) Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Glioblastoma Multiforme Treatment (GBM) Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glioblastoma Multiforme Treatment (GBM) Status and Prospect (2013-2023)
1.5 Global Market Size of Glioblastoma Multiforme Treatment (GBM) (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Merck
  2.1.1 Business Overview
  2.1.2 Glioblastoma Multiforme Treatment (GBM) Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Merck Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva Pharmaceutical
  2.2.1 Business Overview
  2.2.2 Glioblastoma Multiforme Treatment (GBM) Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Arbor Pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Glioblastoma Multiforme Treatment (GBM) Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharmaceutical
  2.4.1 Business Overview
  2.4.2 Glioblastoma Multiforme Treatment (GBM) Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
  2.5.1 Business Overview
  2.5.2 Glioblastoma Multiforme Treatment (GBM) Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Roche Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET COMPETITION, BY PLAYERS

3.1 Global Glioblastoma Multiforme Treatment (GBM) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Glioblastoma Multiforme Treatment (GBM) Players Market Share
  3.2.2 Top 10 Glioblastoma Multiforme Treatment (GBM) Players Market Share
3.3 Market Competition Trend

4 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET SIZE BY REGIONS

4.1 Global Glioblastoma Multiforme Treatment (GBM) Revenue and Market Share by Regions
4.2 North America Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
4.3 Europe Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
4.5 South America Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA GLIOBLASTOMA MULTIFORME TREATMENT (GBM) REVENUE BY COUNTRIES

5.1 North America Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
5.2 USA Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
5.3 Canada Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
5.4 Mexico Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)

6 EUROPE GLIOBLASTOMA MULTIFORME TREATMENT (GBM) REVENUE BY COUNTRIES

6.1 Europe Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
6.2 Germany Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
6.3 UK Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
6.4 France Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
6.5 Russia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
6.6 Italy Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC GLIOBLASTOMA MULTIFORME TREATMENT (GBM) REVENUE BY COUNTRIES

7.1 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
7.2 China Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
7.3 Japan Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
7.4 Korea Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
7.5 India Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA GLIOBLASTOMA MULTIFORME TREATMENT (GBM) REVENUE BY COUNTRIES

8.1 South America Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
8.2 Brazil Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
8.3 Argentina Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
8.4 Colombia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE GLIOBLASTOMA MULTIFORME TREATMENT (GBM) BY COUNTRIES

9.1 Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
9.3 UAE Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
9.4 Egypt Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
9.6 South Africa Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)

10 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET SEGMENT BY TYPE

10.1 Global Glioblastoma Multiforme Treatment (GBM) Revenue and Market Share by Type (2013-2018)
10.2 Global Glioblastoma Multiforme Treatment (GBM) Market Forecast by Type (2018-2023)
10.3 Chemotherapy Revenue Growth Rate (2013-2023)
10.4 Radiotherapy Revenue Growth Rate (2013-2023)
10.5 Gene therapy Revenue Growth Rate (2013-2023)
10.6 Molecular biotechnology Revenue Growth Rate (2013-2023)

11 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET SEGMENT BY APPLICATION

11.1 Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Application (2013-2018)
11.2 Glioblastoma Multiforme Treatment (GBM) Market Forecast by Application (2018-2023)
11.3 Bevacozumab Revenue Growth (2013-2018)
11.4 Carmustine Revenue Growth (2013-2018)
11.5 Temozolomide Revenue Growth (2013-2018)

12 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT (GBM) MARKET SIZE FORECAST (2018-2023)

12.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size Forecast (2018-2023)
12.2 Global Glioblastoma Multiforme Treatment (GBM) Market Forecast by Regions (2018-2023)
12.3 North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
12.4 Europe Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
12.6 South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Glioblastoma Multiforme Treatment (GBM) Picture
Table Product Specifications of Glioblastoma Multiforme Treatment (GBM)
Table Global Glioblastoma Multiforme Treatment (GBM) and Revenue (Million USD) Market Split by Product Type
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Types in 2017
Figure Chemotherapy Picture
Figure Radiotherapy Picture
Figure Gene therapy Picture
Figure Molecular biotechnology Picture
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Application (2013-2023)
Figure Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Applications in 2017
Figure Bevacozumab Picture
Figure Carmustine Picture
Figure Temozolomide Picture
Table Global Market Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Glioblastoma Multiforme Treatment (GBM) Type and Applications
Table Merck Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Type and Applications
Table Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
Table Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Type and Applications
Table Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Type and Applications
Table Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Glioblastoma Multiforme Treatment (GBM) Type and Applications
Table Roche Glioblastoma Multiforme Treatment (GBM) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Players (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Players (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Players in 2016
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Players in 2017
Figure Global Top 5 Players Glioblastoma Multiforme Treatment (GBM) Revenue Market Share in 2017
Figure Global Top 10 Players Glioblastoma Multiforme Treatment (GBM) Revenue Market Share in 2017
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Regions (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Regions (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Regions (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Regions in 2017
Figure North America Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Europe Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure South America Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Table North America Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
Table North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries in 2017
Figure USA Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Canada Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Mexico Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Table Europe Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure Europe Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries in 2017
Figure Germany Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure UK Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure France Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Russia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Italy Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries in 2017
Figure China Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Japan Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Korea Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure India Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Table South America Glioblastoma Multiforme Treatment (GBM) Revenue by Countries (2013-2018)
Table South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries in 2017
Figure Brazil Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Argentina Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Colombia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure UAE Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Egypt Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure Nigeria Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Figure South Africa Glioblastoma Multiforme Treatment (GBM) Revenue and Growth Rate (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) by Type (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Type (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Type (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Type in 2017
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue Forecast by Type (2018-2023)
Figure Global Glioblastoma Multiforme Treatment (GBM) Market Share Forecast by Type (2018-2023)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Figure Global Radiotherapy Revenue Growth Rate (2013-2018)
Figure Global Gene therapy Revenue Growth Rate (2013-2018)
Figure Global Molecular biotechnology Revenue Growth Rate (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue by Application (2013-2018)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Application (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Application (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Share by Application in 2017
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue Forecast by Application (2018-2023)
Figure Global Glioblastoma Multiforme Treatment (GBM) Market Share Forecast by Application (2018-2023)
Figure Global Bevacozumab Revenue Growth Rate (2013-2018)
Figure Global Carmustine Revenue Growth Rate (2013-2018)
Figure Global Temozolomide Revenue Growth Rate (2013-2018)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Glioblastoma Multiforme Treatment (GBM) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
Figure Europe Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
Figure South America Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Glioblastoma Multiforme Treatment (GBM) Revenue Market Forecast (2018-2023)